Compare · ILMN vs LMRI
ILMN vs LMRI
Side-by-side comparison of Illumina Inc. (ILMN) and Lumexa Imaging Holdings Inc. (LMRI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ILMN and LMRI operate in Medical Specialities (Health Care), so they compete in similar markets.
- ILMN is the larger of the two at $24.56B, about 30.1x LMRI ($816.7M).
- Over the past year, ILMN is up 85.1% and LMRI is down 56.6% - ILMN leads by 141.7 points.
- ILMN has been more active in the news (22 items in the past 4 weeks vs 3 for LMRI).
- ILMN has more recent analyst coverage (25 ratings vs 9 for LMRI).
- Company
- Illumina Inc.
- Lumexa Imaging Holdings Inc.
- Price
- $157.32-3.05%
- $8.03-5.64%
- Market cap
- $24.56B
- $816.7M
- 1M return
- +13.43%
- -21.43%
- 1Y return
- +85.13%
- -56.62%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2000
- 2025
- News (4w)
- 22
- 3
- Recent ratings
- 25
- 9
Illumina Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.
Latest ILMN
- Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution
- SVP, Chief People Officer Leckman Patricia sold $127,068 worth of shares (784 units at $162.08), decreasing direct ownership by 3% to 22,042 units (SEC Form 4)
- Director Meister Keith A. sold $107,042,631 worth of shares (669,596 units at $159.86) (SEC Form 4)
- Chief Legal Officer Davies Scott M sold $98,400 worth of shares (615 units at $160.00), decreasing direct ownership by 3% to 21,568 units (SEC Form 4)
- VP, Chief Accounting Officer Ericksen Scott D sold $305,150 worth of shares (2,000 units at $152.57), decreasing direct ownership by 12% to 14,446 units (SEC Form 4)
- Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights
- Amendment: SEC Form 4 filed by Director Meister Keith A.
- Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research
- Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research
- Illumina Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
Latest LMRI
- Lumexa Imaging Announces Joint Venture with Hospital for Special Surgery (HSS) to Expand Advanced Outpatient Imaging in New York
- Director Brodnax Brett bought $253,750 worth of shares (35,000 units at $7.25), increasing direct ownership by 130% to 62,027 units (SEC Form 4)
- Director Cooper Henry Lee bought $223,113 worth of shares (30,000 units at $7.44) (SEC Form 4)
- SEC Form 10-Q filed by Lumexa Imaging Holdings Inc.
- Lumexa Imaging Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure
- Lumexa Imaging Announces First Quarter 2026 Results
- Lumexa Imaging Advances Growth Strategy by Adding Four New Imaging Centers
- SEC Form DEFA14A filed by Lumexa Imaging Holdings Inc.
- SEC Form DEF 14A filed by Lumexa Imaging Holdings Inc.
- Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date